Sanofi Aventis launches its weight loss drug Acomplia today in the UK. The once-a-day pill was shown to help 40 percent of obese participants lose 10 percent of their body weight in clinical trials.
Acomplia works to control appetite by blocking brain activity that regulates the body's energy and its ability to break down fats and sugars in the blood. The drug was found to reduce disease-causing fatty deposits around internal organs.
However, the supposed "blockbuster" drug also comes with side effects, including dizziness, nausea, anxiety, diarrhea and insomnia.
Acomplia -- commonly known as Rimonabant -- will be made available in the UK to obese patients with a body mass index (BMI) of 30 or more, and to overweight patients with a BMI of 27 or more who either lack "good" HDL cholesterol, have too much "bad" LDL cholesterol, or are at risk of developing type 2 diabetes. Rimonabant will only be available to those patients who also commit to making healthy dietary and exercise changes.
Critics of the drug say diet and exercise -- without prescription drugs -- should be enough to help people lose weight, especially considering that Acomplia comes with potentially harmful side effects. Many natural alternatives exist that control cravings and reduce appetite without the use of expensive and potentially dangerous prescription drugs.
Other weight loss options :
Acomplia
Rimonabant
Weight loss
Source:-www.newstarget.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment